Howard Welgus
Fenton, MONPI 1023391901
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $972,321 of the $1,089,066 with a category attached, or 89.3%. Every reported general payment came from a single manufacturer, Arcutis Biotherapeutics, Inc.. 2025 is the largest year on record at $632,558, 4.4 times the $144,237 reported in 2023.
Across 20 payments — averaging $54,453 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$1.1M
What the payments were for
- Consulting fees$112,12510%
- Speaking & faculty fees$972,32189%
- Travel & lodging$4,6210%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 20 | $1,089,066 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.